APOC3 and atherosclerosis: The first 2 models allowed us to study the impact of apoC-III on atherogenesis dependent on a reduction in triglyceride levels, while the third model evaluated a possible role of the proinflammatory properties of apoC-III in atherosclerosis development, independent of changes in plasma triglycerides.